Autopsy report · NCT05473234
Azithromycin for Severe Acute Malnutrition in CMAM, Nigeria
Cause of deathSlow enrollment
“Study was halted due to low follow-up rates and issues with data collection”
Life of this trial
- Registered 3 months before it started.
- Ran for about 1 year 2 months before it stopped.
- 310 participants enrolled.
- Results were posted on the registry 1 year 3 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- University of California, San Francisco
- Sponsor type
- University, hospital or other
- Conditions
- Severe Acute Malnutrition
- Interventions
- Azithromycin; Amoxicillin
- Participants
- 310
- Sites
- 1
- Countries
- Nigeria
Trials that died the same way
- Pre-operative Zoledronate in Triple Negative Breast Cancer
“The study stopped prematurely due to the low accrual rate” - Long-term Clinical Effectiveness of the Delta Xtend Reverse Total Shoulder
“Study was stopped due to low follow-up compliance at study sites.” - Hirschsprung Disease Trends in the United States: Analysis of the National Inpatient Sample
“Per PI, the study was terminated prematurely since the data collection was completed” - Prevention of NAFLD in Hispanic Children
“Study was terminated due to a lack of funding. Data collection was completed for 12-month outcomes; however, funding limitations prevented follow-up for longer timeframes, and some outcomes were not fully collected.” - Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer
“The study was halted because enrollment was too slow”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.